Abstract |
Many natural flavonoids have cytostatic and apoptotic properties; however, we little know whether the effect of synthetic 3-hydroxyflavone on metastasis and tumor growth of human osteosarcoma. Here, we tested the hypothesis that 3-hydroxyflavone suppresses human osteosarcoma cells metastasis and tumor growth. 3-hydroxyflavone, up to 50 μM without cytotoxicity, inhibited U2OS and 143B cells motility, invasiveness and migration by reducing matrix metalloproteinase (MMP)-2 and urokinase-type plasminogen activator ( u-PA) and also impaired cell adhesion to gelatin. 3-hydroxyflavone significantly reduced p- focal adhesion kinase (FAK) Tyr397, p-FAK Tyr925, p- steroid receptor coactivator (Src), p- mitogen/ extracellular signal-regulated kinase ( MEK)1/2, p- myosin light chain (MLC)2 Ser19, epithelial cell adhesion molecule, Ras homolog gene family (Rho)A and fibronectin expressions. 3-hydroxyflavone also affected the epithelial-mesenchymal transition (EMT) by down-regulating expressions of Vimentin and α- catenin with activation of the transcription factor Slug. In nude mice xenograft model and tail vein injection model showed that 3-hydroxyflavone reduced 143B tumor growth and lung metastasis. 3-hydroxyflavone possesses the anti-metastatic activity of U2OS and 143B cells by affecting EMT and repressing u-PA/ MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and suppresses 143B tumor growth in vivo. This may lead to clinical trials of osteosarcoma chemotherapy to confirm the promising result in the future.
|
Authors | Ko-Hsiu Lu, Pei-Ni Chen, Yi-Hsien Hsieh, Chin-Yin Lin, Fu-Yuan Cheng, Peng-Chou Chiu, Shu-Chen Chu, Yih-Shou Hsieh |
Journal | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
(Food Chem Toxicol)
Vol. 97
Pg. 177-186
(Nov 2016)
ISSN: 1873-6351 [Electronic] England |
PMID | 27600294
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 Elsevier Ltd. All rights reserved. |
Chemical References |
- Biomarkers, Tumor
- Flavonoids
- Myosin Light Chains
- myosin light chain 2
- Focal Adhesion Protein-Tyrosine Kinases
- src-Family Kinases
- Extracellular Signal-Regulated MAP Kinases
- MAP Kinase Kinase 1
- Urokinase-Type Plasminogen Activator
- Matrix Metalloproteinase 2
- Cardiac Myosins
- rhoA GTP-Binding Protein
- 3-hydroxyflavone
|
Topics |
- Adolescent
- Animals
- Apoptosis
(drug effects)
- Biomarkers, Tumor
(metabolism)
- Blotting, Western
- Bone Neoplasms
(metabolism, pathology, prevention & control)
- Cardiac Myosins
(metabolism)
- Cell Adhesion
(drug effects)
- Cell Movement
(drug effects)
- Cell Proliferation
(drug effects)
- Child
- Epithelial-Mesenchymal Transition
(drug effects)
- Extracellular Signal-Regulated MAP Kinases
(metabolism)
- Female
- Flavonoids
(pharmacology)
- Focal Adhesion Protein-Tyrosine Kinases
(metabolism)
- Humans
- Immunoenzyme Techniques
- MAP Kinase Kinase 1
(metabolism)
- Matrix Metalloproteinase 2
(metabolism)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Myosin Light Chains
(metabolism)
- Osteosarcoma
(metabolism, prevention & control, secondary)
- Signal Transduction
(drug effects)
- Tumor Cells, Cultured
- Urokinase-Type Plasminogen Activator
(metabolism)
- Xenograft Model Antitumor Assays
- rhoA GTP-Binding Protein
(metabolism)
- src-Family Kinases
(metabolism)
|